04/16/2024 11:16 AM | Johnson & Johnson (Filer)
| Form 8-K/A | |
04/16/2024 6:06 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 4:05 PM | Contineum Therapeutics, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/10/2024 4:12 PM | Contineum Therapeutics, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G | |
04/05/2024 4:29 PM | Johnson & Johnson (Filed by) Shockwave Medical, Inc. (Subject)
| Form DFAN14A | |
03/27/2024 8:48 AM | Johnson & Johnson (Subject) National Legal & Policy Center (Filed by)
| Form PX14A6G | |
03/13/2024 3:28 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/13/2024 3:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 6:42 AM | Johnson & Johnson (Filer)
| Form ARS | |
03/13/2024 6:35 AM | Johnson & Johnson (Filer)
| Form DEF 14A | |
03/13/2024 6:37 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/13/2024 6:39 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/06/2024 2:42 PM | CVRx, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:58 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:54 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:12 PM | Johnson & Johnson (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 4:23 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
02/15/2024 3:53 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
02/12/2024 6:24 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 11:55 AM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 11:35 AM | Johnson & Johnson (Subject) Taubert Jennifer L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024 3:24 PM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 4:07 PM | BiomX Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:52 PM | CVRx, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:32 PM | Johnson & Johnson (Filed by) Johnson & Johnson (Filed by) Nanobiotix S.A. (Subject)
| Form SC 13G/A | |
01/30/2024 11:46 AM | Johnson & Johnson (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/29/2024 3:50 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/24/2024 11:51 AM | Johnson & Johnson (Filed by) Kenvue Inc. (Subject)
| Form SC 13G | |
01/23/2024 6:45 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 4:08 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 4:22 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 7:22 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
12/08/2023 3:33 PM | Johnson & Johnson (Issuer) Woods Eugene A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/07/2023 4:17 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:42 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 6:52 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 3:30 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 3:56 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/23/2023 3:48 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 6:33 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:36 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 6:46 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 4:02 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 3:53 PM | Johnson & Johnson (Reporting) Kenvue Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:04 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/23/2023 5:37 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/21/2023 5:52 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/21/2023 5:38 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/18/2023 4:11 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023 3:53 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023 5:23 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/16/2023 8:22 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/16/2023 3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/15/2023 3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/14/2023 3:44 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/11/2023 3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/04/2023 3:32 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023 3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023 7:03 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/01/2023 3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/31/2023 3:06 PM | Johnson & Johnson (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/28/2023 7:59 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/27/2023 4:52 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Will this $2 AI stock double overnight? (Ad) It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract.
What's more, this groundbreaking firm is trading for less than $2 a share! Click here to learn more >>> |
07/27/2023 4:52 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2023 3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject) Kenvue Inc. (Filed by)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |